s6y

Evotec SE

Ticker
EVO, EVOTF
CIK
1412558
Industry
Pharmaceutical Preparations
Formerly
Evotec AG

Financials 2

  1. NT 20-F Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F for period ending Dec 31, 2023
  2. NT 20-F Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F for period ending Dec 31, 2022

Ownership 7

  1. SC 13D Major Shareholders
  2. SC 13G/A Major Shareholders
  3. SC 13G/A Major Shareholders
  4. SC 13G Major Shareholders
  5. SC 13D Major Shareholders
  6. SC 13G/A Major Shareholders
  7. SC 13G Major Shareholders

Prospectus 24

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  3. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  4. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  5. DRSLTR Correspondence Related to Draft Registration Statement
  6. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  7. DRSLTR Correspondence Related to Draft Registration Statement
  8. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  9. S-8 POS Post-effective amendment to a S-8 registration statement
  10. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

All 24 prospectus filings

Other 157

  1. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. SCHEDULE 13D/A
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  6. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  7. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  8. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  9. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  10. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

All 157 other filings